Context and Objective: The primary purpose of this study was to detect and quantify 3-iodothyronamine (T1AM), an endogenous biogenic amine related to thyroid hormone, in human blood. Design: T1AM, total T3, and total T4 were assayed in serum by a novel HPLC tandem mass spectrometry assay, which has already been validated in animal investigations, and the results were related to standard clinical and laboratory variables. Setting and Patients: The series included one healthy volunteer, 24 patients admitted to a cardiological ward, and 17 ambulatory patients suspected of thyroid disease, who underwent blood sampling at admission for routine diagnostic purposes. Seven patients were affected by type 2 diabetes, and six patients showed echocardiographic evidence of impaired left ventricular function. Interventions: No intervention or any patient selection was performed. Main Outcome Measures: serum T1AM, total and free T3 and T4, routine chemistry, routine hematology, and echocardiographic parameters were measured. Results: T1AMwas detected in all samples, and its concentration averaged 0.219 _ 0.012 pmol/ml. The T1AM concentration was significantly correlated to total T4 (r _ 0.654, P _ 0.001), total T3 (r _ 0.705, P _ 0.001), glycated hemoglobin (r _ 0.508, P _ 0.013), brain natriuretic peptide (r _ 0.543, P_0.016), and_-glutamyl transpeptidase (r_0.675, P_0.001). In diabetic vs. nondiabetic patients T1AM concentration was significantly increased (0.232 _ 0.014 vs. 0.203 _ 0.006 pmol/ml, P _ 0.044), whereas no significant difference was observed in patients with cardiac dysfunction. Conclusions: T1AM is an endogenous messenger that can be assayed in human blood. Our results are consistent with the hypothesis that circulating T1AM is produced from thyroid hormones and encourage further investigations on the potential role of T1AM in insulin resistance and heart failure.
Detection of 3-Iodothyronamine in human patients: a preliminary study
SABA, ALESSANDRO;TONACCHERA, MASSIMO;VITTI, PAOLO;ZUCCHI, RICCARDO
2012-01-01
Abstract
Context and Objective: The primary purpose of this study was to detect and quantify 3-iodothyronamine (T1AM), an endogenous biogenic amine related to thyroid hormone, in human blood. Design: T1AM, total T3, and total T4 were assayed in serum by a novel HPLC tandem mass spectrometry assay, which has already been validated in animal investigations, and the results were related to standard clinical and laboratory variables. Setting and Patients: The series included one healthy volunteer, 24 patients admitted to a cardiological ward, and 17 ambulatory patients suspected of thyroid disease, who underwent blood sampling at admission for routine diagnostic purposes. Seven patients were affected by type 2 diabetes, and six patients showed echocardiographic evidence of impaired left ventricular function. Interventions: No intervention or any patient selection was performed. Main Outcome Measures: serum T1AM, total and free T3 and T4, routine chemistry, routine hematology, and echocardiographic parameters were measured. Results: T1AMwas detected in all samples, and its concentration averaged 0.219 _ 0.012 pmol/ml. The T1AM concentration was significantly correlated to total T4 (r _ 0.654, P _ 0.001), total T3 (r _ 0.705, P _ 0.001), glycated hemoglobin (r _ 0.508, P _ 0.013), brain natriuretic peptide (r _ 0.543, P_0.016), and_-glutamyl transpeptidase (r_0.675, P_0.001). In diabetic vs. nondiabetic patients T1AM concentration was significantly increased (0.232 _ 0.014 vs. 0.203 _ 0.006 pmol/ml, P _ 0.044), whereas no significant difference was observed in patients with cardiac dysfunction. Conclusions: T1AM is an endogenous messenger that can be assayed in human blood. Our results are consistent with the hypothesis that circulating T1AM is produced from thyroid hormones and encourage further investigations on the potential role of T1AM in insulin resistance and heart failure.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
